Amgen Inc

Common Name
Amgen
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
28,000
Ticker
AMGN
Exchange
NASDAQ/NGS
Description
Amgen Inc. is a leading biotechnology company focused on the discovery, development, manufacturing, and marketing of human therapeutics. Established in 1980 and headquartered in Thousand Oaks, Califor...

Amgen's GHG Emissions Data Preview

In 2024, Amgen completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Amgen has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Amgen's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Amgen’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Amgen’s data sources below and access millions more through our Disclosure Search.

a. Amgen's ESG Data Spreadsheet 2024
Trace every data point back to Amgen’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. Amgen's CDP Climate sourced from company’s website 2023
Trace every data point back to Amgen’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Amgen's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Amgen amounted to 275,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Amgen increased by 1.48%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Amgen's Scope 1 Emissions Over Time

201920202021202220232024040 k80 k120 k160 ktCO2e+2%-4%-2%+17%-4%
  • Total Scope 1
  • Year-over-Year Change

What are Amgen's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Amgen were 147,000 metric tons of CO₂ equivalent (tCO₂e). a

Has Amgen reduced its Scope 1 emissions over time?

Since 2019, Amgen's Scope 1 emissions have increased by 8.12%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), Amgen's Scope 1 emissions decreased by 3.92%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Amgen's Scope 2 emissions?

In 2024, Amgen reported Scope 2 greenhouse gas (GHG) emissions of 14,000 tCO₂e using the market-based method and 128,000 tCO₂e using the location-based method. a

Has Amgen reduced its Scope 2 emissions over time?

Since 2019, Amgen's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 26.4%, reflecting a declining long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), Amgen's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Amgen 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Amgen use for Scope 2 reporting?

In 2024, Amgen reported its Scope 2 emissions using the market-based method and using the location-based method. a

Amgen's Scope 2 Emissions Over Time

201920202021202220232024045 k90 k135 k180 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Amgen's Value Chain Emissions

In 2024, Amgen reported 1,705,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Amgen includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Amgen's Scope 3 Emissions Over Time

2019202020212022202320240900 k1.8 M2.7 M3.6 MtCO2e-5%+34%-9%-57%+23%
  • Total Scope 3
  • Year-over-Year Change

What are Amgen's Scope 3 emissions?

In 2024, Amgen reported total Scope 3 emissions of 1,705,000 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 99.94% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.06% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Amgen reduced its Scope 3 emissions over time?

Since 2019, Amgen's Scope 3 emissions have decreased by 38.51%, reflecting a declining long-term trend in Scope 3 emissions over time. a

Compared to the previous year (2023), Amgen's Scope 3 emissions increased by 23.19%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Amgen disclose?

In 2024, Amgen reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Amgen's Scope 3 emissions?

In 2024, the largest contributors to Amgen's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 946,000 tCO₂e (55.94%)
  • Capital Goods (Cat. 2): 221,000 tCO₂e (13.07%)
  • Downstream Transportation and Distribution (Cat. 9): 213,000 tCO₂e (12.6%)

Amgen's Scope 3 Emissions by Categories

DownstreamTransportation andDistribution(Cat. 9)(12.6%)Capital Goods(Cat. 2)(13.1%)Purchased Goods andServices (Cat. 1)(55.9%)

Insights into Amgen's Total Carbon Footprint

In 2024, Amgen reported a total carbon footprint of 1,980,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 19.64% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Amgen's total carbon footprint was Scope 3 emissions, accounting for 86.11% of the company's total carbon footprint, followed by Scope 1 emissions at 7.42%. a

Want Full Access to Amgen's GHG Emissions Dataset?
Sign Up